Abstract Title:

Preventive effects of curcumin and dexamethasone on lung transplantation-associated lung injury in rats.

Abstract Source:

Crit Care Med. 2008 Apr;36(4):1205-13. PMID: 18379247

Abstract Author(s):

Jiayuan Sun, Weigang Guo, Yong Ben, Jinjun Jiang, Changjun Tan, Zude Xu, Xiangdong Wang, Chunxue Bai

Article Affiliation:

Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, PR China.

Abstract:

OBJECTIVE: To investigate potential effects of curcumin or dexamethasone on lung transplantation-associated lung injury.

DESIGN: Prospective, randomized, controlled study.

SETTING: Research laboratory.

SUBJECTS: Adult male Sprague-Dawley rats.

INTERVENTIONS: Sham-operated rats were used as time-matched controls. Experimental rats were subjected to unilateral orthotopic lung transplantation with 4 hrs of cold ischemia followed by 2 hrs (or 24 hrs) of reperfusion. Animals were randomly assigned to vehicle-, curcumin-, or dexamethasone-treated groups.

MEASUREMENTS AND MAIN RESULTS: Transplantation-associated lung injury was characterized by an increased alveolar-capillary permeability and myeloperoxidase activity and decreased levels of arterial oxygen tension/inspired oxygen concentration ratio. Pretreatment with curcumin and dexamethasone significantly prevented barrier disruption, lung edema, tissue inflammation, and decreased PaO2 at the early stage of posttransplantation. Nuclear factor-kappaB in transplanted lungs was activated, accompanied by an increase in messenger RNA levels and protein content of tumor necrosis factor-alpha, interleukin-6, and matrix metalloproteinase-9 in lung graft. Those changes were prevented by pretreatment with curcumin and dexamethasone.

CONCLUSIONS: Curcumin can be an alternative therapy for protecting lung transplantation-associated injury by suppressing nuclear factor-kappaB-mediated expression of inflammatory genes.

Study Type : Animal Study

Print Options


Key Research Topics